Clinical Standards
The duties of this committee shall be to develop and maintain the clinical standards of treating patients with TMS. These guidelines shall cover patient selection, use of protocols, and the level of training and supervision required for administration of treatment. As other indications arise, the committee shall develop and maintain further standards consistent with the previous standards.
The Clinical Standards committee meets for one hour, on the 2nd Thursday of the month at 2:00pm ET/11:00am PT.
Clinical Standards Chairs

Daniel M. Blumberger
MD
Ontario, Canada

Joseph J Taylor
MD, PhD
Massachusetts, United States
Articles
Meetings & Minutes
Meeting Minutes
Meeting Minutes
December 12th, 2024
Meeting Minutes
November 14th, 2024
Meeting Minutes
October 10th, 2024
Meeting Minutes
September 12th, 2024
Meeting Minutes
August 8th, 2024
Meeting Minutes
July 11th, 2024
Meeting Minutes
May 9th, 2024
Meeting Minutes
April 11th, 2024
Meeting Minutes
March 14th, 2024
Meeting Minutes
February 8th, 2024
Meeting Minutes
January 11th, 2024
Meeting Minutes
Novemeber 9th, 2023
Meeting Minutes
October 12th, 2023
Meeting Minutes
September 21st, 2024
Meeting Minutes
August 10th, 2023
Meeting Minutes
July 13th, 2023
Meeting Minutes
June 8th, 2023
Meeting Minutes
April 13th, 2023
Meeting Minutes
March 9th, 2023
Meeting Minutes
February 9th, 2023
Meeting Minutes
January 12th, 2023
Resources
Guidelines for TMS Treaters
May 19th, 2023
Theta Burst Statement
March 21st, 2023
Preservation of TMS Statement
December 8th, 2023
Revised Statement Regarding SAINT Protocol
December 8th, 2022
rTMS Clarifying Statement
February 10th, 2023